The purpose of the trial is to evaluate the completeness of struts coverage and vessel wall response (strut malapposition, neoin-timal formation) to the bio-active-stent (BAS) versus ever-olimus-eluting stent (EES) implanted for the treatment of the culprit lesion in acute coronary syndrome.
A prospective, randomized and controlled study comparing the coverage of the BAS and EES implanted in acute coronary syndrome. Clinical follow-up at 1, 6, 12 and 18 months. OCT analysis at the time of the 6 to 8 months follow-up.
Study Type
OBSERVATIONAL
Enrollment
40
Satakunta Central Hospital
Pori, Finland
Uncovered stent struts
OCT number of uncovered stent struts for BAS versus EES.
Time frame: 6-8 months
Cardiac death,MI, stent thrombosis (ST) and TLR.
Device oriented composite endpoint, defined as cardiac death,MI, stent thrombosis (ST) and TLR at at 1, 6, 12 and 18 months.
Time frame: 1, 6, 12 and 18 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.